GlassScriptPhysician profile
Eric J Neumann
NPI 1841796885
$9,469.37
in general payments reported to CMS, 2019-2025
7 companies · $2,541 in 2025
The $2,541 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,508 · 2024: $5,421 · 2025: $2,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,179 · Food and Beverage: $2,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,179.25 |
| Food and Beverage | $2,290.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,839.26 | 2024-2025 | Mazor X System, Cd Horizon Spinal System, Midas Rex |
| Synthes Gmbh | $2,744.52 | 2023-2024 | |
| Globus Medical, INC. | $949.49 | 2024 | Xlif |
| Depuy Synthes Sales INC. | $758.29 | 2023-2024 | Teligen, Conduit, Expedium Verse |
| Arthrex, INC. | $105.42 | 2024 | Arthrex |
| Medical Device Business Services, INC. | $46.51 | 2024 | Teligen |
| Orthofix Medical, INC. | $25.88 | 2024 | Cervical-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Neumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.